Key Highlights
- Stephens began tracking Netskope (NTSK) with an overweight stance and $21 price objective, suggesting 24% potential appreciation from the $17 level.
- Shares of NTSK jumped 15.65% amid multiple analyst upgrades and increased price objectives from major firms including JPMorgan, RBC Capital, and BMO Capital.
- The cybersecurity company exceeded Q2 fiscal 2027 expectations, reporting a 3-cent per share loss versus the anticipated 7-cent deficit, while revenue reached $221 million against forecasts of $214.2 million.
- Management increased full-year projections following the quarterly performance, with annual recurring revenue expanding 27% compared to the previous year.
- The stock has climbed 75% during the last half-year period, despite being down 16% for the current year, with analysts flagging continued operating deficits as a risk factor.
Shares of Netskope (NTSK) experienced a significant 15.65% rally on Monday following a series of upgraded price objectives from Wall Street analysts and new research coverage that boosted investor confidence. Trading near $17 prior to the advance, the stock now has a fresh $21 price objective from Stephens.
Netskope, Inc. Class A Common Stock, NTSK
Stephens launched its research coverage with an overweight recommendation, establishing the $21 objective using an enterprise value-to-forward revenue metric of approximately 9x. This target suggests roughly 24% upside potential from present trading levels.
The research firm indicated that market sentiment regarding the SASE sector and Netskope in particular appears excessively pessimistic. Analysts at Stephens believe investors are underestimating the company’s expansion opportunities and market position.
According to Stephens, Netskope should generate revenue expansion exceeding 20% on a consistent basis while improving profitability margins. The company has already demonstrated 30% revenue growth across the trailing twelve-month period, which analysts cite as proof of effective management execution.
The coverage launch followed impressive fiscal Q2 2027 financial results. Netskope posted an adjusted deficit of merely 3 cents per share, significantly outperforming the 7-cent loss anticipated by analysts.
Strong Quarter Prompts Guidance Increases
Quarterly revenue totaled $221 million, exceeding the consensus projection of $214.2 million. After the solid performance, Netskope elevated its full-year financial guidance.
Multiple additional research houses increased their price objectives following the earnings announcement. BMO Capital elevated its target to $18, highlighting consistent quarterly execution and enhanced annual recurring revenue projections.
Piper Sandler increased its objective to $20, observing accelerating momentum in Netskope’s AI security product pipeline. RBC Capital similarly advanced to a $20 target, emphasizing the 27% year-over-year expansion in annual recurring revenue.
Morgan Stanley established its price objective at $16, crediting the company’s positive trajectory to AI-powered growth initiatives and successful customer acquisition.
The flurry of analyst activity emerged after management meetings with JPMorgan and updated analysis from RBC and BMO, which collectively indicated strengthening confidence in the company’s forward prospects.
Path to Profitability Remains Ongoing
Notwithstanding the optimistic analyst sentiment, Netskope continues to generate substantial operating deficits and maintains a leveraged financial structure. Stephens recognized these concerns, observing that any deceleration in performance or expansion could pressure the valuation.
Four analysts have recently adjusted their earnings projections higher, based on InvestingPro data. The analytics platform currently characterizes the stock as overvalued compared to its Fair Value calculation.
NTSK has advanced 75% across the preceding six-month window, although it remains lower by approximately 16% year to date. Average daily share volume stands at roughly 5.5 million.
Stephens suggested that robust second-half fiscal 2027 performance could provide additional momentum through estimate increases and valuation multiple expansion.



